Vaccinology | Biotechnology | Rna Therapeutics
Vaccinology · Biotechnology · RNA Therapeutics · Innovation in Healthcare
Specialties
VaccinologyBiotechnologyRNA TherapeuticsInnovation in HealthcareStartups in Life Sciences
Professional Services
RNA Vaccine DevelopmentBiotechnology ConsultingInnovation StrategyHealthcare Startups AdvisoryResearch CollaborationVaccine Technology Transfer
Professional Timeline
Founder of CureVac
Ingmar Hoerr founded CureVac, a leading biotechnology company specializing in RNA-based therapies.
CureVac
Pioneered RNA Vaccine Technology
He developed the foundational technology for RNA vaccines, significantly impacting global vaccination strategies.
CureVac
Nobel Prize Nominee
Ingmar Hoerr has been nominated for a Nobel Prize for his groundbreaking work in RNA vaccinology.
Various
European Innovation Council Ambassador
Currently serving as an Ambassador for the European Innovation Council, promoting innovation from 2021 to 2027.
European Innovation Council
Client Reviews
No reviews yet. Be the first to leave one below.
Leave a Review